Image-guided surgery and sonodynamic therapy with stroma-targeted theranostic nanoclusters
Image-guided surgery and sonodynamic therapy with stroma-targeted theranostic nanoclusters
批准号:
10541160
负责人:
Andrew Tsourkas
金额:
$36.41万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-01 至 2024-08-31
关键词:
AblationAddressAzidesBindingBiological MarkersBreast Cancer ModelBreast Cancer PatientBreast-Conserving SurgeryCancer EtiologyCarcinomaCell-Mediated CytolysisCellsCessation of lifeClinicalClinical ResearchContrast MediaDiagnosisDiameterDrug KineticsExcisionExtracellular MatrixExtravasationFibroblastsFluorescent DyesFrequenciesGenerationsGenetic EngineeringGoalsHumanImageImage-Guided SurgeryIn VitroIndocyanine GreenLigandsLightLocalized DiseaseMagnetic ResonanceMagnetic Resonance ImagingMammary NeoplasmsModelingMonoclonal AntibodiesMusNanotechnologyNeoplasm MetastasisNormal tissue morphologyOperative Surgical ProceduresOpticsPUVA PhotochemotherapyPathologyPatientsPenetrationPhotosensitizing AgentsPhysiciansProcessProteinsRadiologic FindingReactive Oxygen SpeciesRecombinant AntibodyRecombinantsRecurrenceRegimenRelapseResidual CancersResidual NeoplasmSafetySiteSpecificityStromal CellsSurfaceTherapeuticTimeTissuesToxic effectTumor ExpansionVisualWomananalogcancer cellcancer therapychemical propertyclinical investigationcontrast enhancedcytotoxicitydesignimage guidedimaging propertiesimprovedinnovationinsightiron oxide nanoparticlemalignant breast neoplasmmouse modelnanoclusternanoformulationnanoparticlenoveloptical imagingpharmacokinetics and pharmacodynamicspreventresponsesuperparamagnetismtheranosticstrendtumortumor initiationultrasounduptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The majority of women with breast cancer undergo breast-conserving surgery, but in >20% of the cases it is
post-surgically determined that the margins are not tumor free and additional surgery is necessary. One
potential solution is the use of optical image-guided surgery to improve intraoperative margin assessment. We
recently found that the near-infrared fluorescent dye, indocyanine green (ICG), can be used to help
differentiate breast tumor tissue from normal tissue in clinical investigations; however, a low specificity was
found to lead to false-positives. We hypothesize that targeted nanoparticles capable of carrying large payloads
of ICG could be used to confer additional specificity (and sensitivity) during surgery.
A recent trend in more aggressive cancer therapies involves treating patients with photodynamic therapy (PDT)
as anadjunct to surgery. Clinical studies have shown that this can improve overall survival. However, PDT is
hampered by the poor specificity of photosensitizers and the limited depth penetration of the excitation light.
We propose to utilize targeting ligands to overcome the poor selectivity of sensitizing agents and ultrasound,
instead of light, to activate the sensitizing agents to improve tissue penetration, i.e. sonodynamic therapy
(SDT). ICG will be used as the sensitizer, thus allowing a single agent to be used for both imaging and therapy.
The goal of this proposal is to develop multifunctional, targeted nanoparticles that allow intraoperative image-
guided surgery and SDT to be performed in a novel combination regimen for treating breast cancer.
Multifunctional nanoparticles will be prepared with ICG and superparamagnetic iron oxide nanoparticles
(SPIONs) in a single nanoformulation. The nanoparticles will be designed to target fibroblast activating protein
(FAP) on the tumor stroma. We hypothesize that stromal cells will be a favorable target because they are
located at the invasive front of the tumor, they are genetically stable, and they are required for expansion of
tumor initiating cells. Superparamagnetic iron oxide nanoparticle (SPION)-enhanced MR imaging is expected
to enable preoperative radiologic findings to be directly related to the visual presentation of pathology during
surgery. ICG-enhanced intraoperative image-guided surgery will enable more complete resection, resulting in
fewer residual cancer cells after surgery. SDT will enable the ablation of any residual disease. We believe that
this innovative nanotechnology will profoundly improve the ability of physicians to completely eradicate local
disease in breast cancer patients, resulting in fewer re-excisions and an improvement in survival.
The specific aims of this proposal are (1) . Synthesize and characterize the physical-chemical properties of
FAP-targeted ICG-coated SPION nanoclusters.; (2) . Characterize binding, uptake and cytotoxicity of ICG-
coated SPION nanoclusters in vitro; and (3) Evaluate the pharmacokinetics, contrast enhancement, and ability
of ICG-coated SPION nanoclusters to enhance intraoperative image-guided resection and SDT in a murine
model of breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC
-
批准号:10426358
-
项目类别:
-
资助金额:$44.74万
-
财政年份:2021
-
负责人:Andrew Tsourkas
-
依托单位:
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC
-
批准号:10586052
-
项目类别:
-
资助金额:$44.74万
-
财政年份:2021
-
负责人:Andrew Tsourkas
-
依托单位:
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC
-
批准号:10297166
-
项目类别:
-
资助金额:$44.74万
-
财政年份:2021
-
负责人:Andrew Tsourkas
-
依托单位:
Image-guided surgery and sonodynamic therapy with stroma-targeted theranostic nanoclusters
-
批准号:10318642
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2020
-
负责人:Andrew Tsourkas
-
依托单位:
Image-guided surgery and sonodynamic therapy with stroma-targeted theranostic nanoclusters
-
批准号:9886512
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2020
-
负责人:Andrew Tsourkas
-
依托单位:
Modular approach for the delivery of antibodies into the cytoplasm of cells
-
批准号:9975797
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2019
-
负责人:Andrew Tsourkas
-
依托单位:
Modular approach for the delivery of antibodies into the cytoplasm of cells
-
批准号:10414929
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2019
-
负责人:Andrew Tsourkas
-
依托单位:
Modular approach for the delivery of antibodies into the cytoplasm of cells
-
批准号:10218119
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2019
-
负责人:Andrew Tsourkas
-
依托单位:
Modular approach for the delivery of antibodies into the cytoplasm of cells
-
批准号:10654576
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2019
-
负责人:Andrew Tsourkas
-
依托单位:
Preparation of site-specific antibody-drug conjugates by proximity-based sortase ligation
-
批准号:9404082
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2017
-
负责人:Andrew Tsourkas
-
依托单位:
Tools for site-specific antibody immobilization for immunoassays
-
批准号:9253466
-
项目类别:
-
资助金额:$22.46万
-
财政年份:2017
-
负责人:Andrew Tsourkas
-
依托单位:
A facile method for producing bispecific antibodies from full-length IgG
-
批准号:8755740
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2014
-
负责人:Andrew Tsourkas
-
依托单位:
Bioconjugate technique for site-specific attachment of IgG onto nanoparticles
-
批准号:8822592
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2014
-
负责人:Andrew Tsourkas
-
依托单位:
Gold-Loaded Polymeric Micelles
-
批准号:8445293
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2012
-
负责人:Andrew Tsourkas
-
依托单位:
Gold-Loaded Polymeric Micelles
-
批准号:8302109
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2012
-
负责人:Andrew Tsourkas
-
依托单位:
Tumor-Targeted Paramagnetic Porous Polymersomes
-
批准号:8252148
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2011
-
负责人:Andrew Tsourkas
-
依托单位:
Tumor-Targeted Paramagnetic Porous Polymersomes
-
批准号:8088978
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2011
-
负责人:Andrew Tsourkas
-
依托单位:
Highly Paramagnetic, Biodegradable Nanoclusters for Imaging Prostate Cancer
-
批准号:8084475
-
项目类别:
-
资助金额:$34.41万
-
财政年份:2011
-
负责人:Andrew Tsourkas
-
依托单位:
Highly Paramagnetic, Biodegradable Nanoclusters for Imaging Prostate Cancer
-
批准号:8233993
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2011
-
负责人:Andrew Tsourkas
-
依托单位:
Highly Paramagnetic, Biodegradable Nanoclusters for Imaging Prostate Cancer
-
批准号:8445382
-
项目类别:
-
资助金额:$30.94万
-
财政年份:2011
-
负责人:Andrew Tsourkas
-
依托单位:
海外基金